ALECENSA HARD CAPSULE 150MG Singapore - English - HSA (Health Sciences Authority)

alecensa hard capsule 150mg

roche singapore pte. ltd. - alectinib hydrochloride 161.33 mg eqv. alectinib - capsule - alectinib hydrochloride 161.33 mg eqv. alectinib 150 mg

Alecensa 150mg hard Capsule 161.33 MG/1 CAP Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

alecensa 150mg hard capsule 161.33 mg/1 cap

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - alectinib hcl 161.33 mg/1 cap - 161.33 mg/1 cap

Alecensa New Zealand - English - Medsafe (Medicines Safety Authority)

alecensa

roche products (nz) ltd - alectinib hydrochloride 161.33mg equivalent to alectinib 150mg - capsule - 150 mg - active: alectinib hydrochloride 161.33mg equivalent to alectinib 150mg excipient: black ink (alecensa) carmellose calcium carnauba wax carrageenan hyprolose hypromellose lactose monohydrate magnesium stearate maize starch potassium chloride sodium laurilsulfate titanium dioxide - alecensa is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive, locally advanced or metastatic non-small cell lung cancer (nsclc).